Please Wait
Applying Filters...
menu
    • menu
    Top news of 2025: Drugmakers invest in US capacities, agree to lower Medicaid prices; Pfizer buys obesity-focused biotech Metsera

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Ethenzamide (TN)

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 233Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    30/12/2025 Cheng Fong Chemical Co., Ltd
    China
    		 Kukjeon Pharmaceutical Co., Ltd. 20230420-211-J-1480 Ethenzamide 2023-04-20 Cheng Fong Chemical Co., Ltd. Taiwan No.19, Gong 4th Rd., Dayuan Dist., Taoyuan County 337, Taiwan(ROC)
    30/12/2025 Cheng Fong Chemical Co., Ltd
    China
    		 IMCD Korea Co., Ltd. 20230420-211-J-1480(6) Ethenzamide 2024-10-07 Cheng Fong Chemical Co., Ltd. Taiwan No. 19, Gong 4th Rd., Dayuan Dist., Taoyuan City 337, Taiwan (ROC)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.